Heparin-induced thrombocytopenia type II;Heparininduzierte Thrombocytopenie Typ II

Chirurg

Volumn 70, Issue 10, 1999, Pages 1149-1155

  Eder, S ^a   Hamann, H ^a  

^a Kreiskrankenhaus   (Germany)

Author keywords

Anticoagulation; Heparin induced thrombocytopenia type II; Prophylaxis; Thromboembolic complications

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HUMAN; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOEMBOLISM;

ANTICOAGULANTS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PLATELET COUNT; THROMBOCYTOPENIA; THROMBOEMBOLISM;

EID: 0033211193     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001040050878     Document Type: Article

References (39)

1. AbuRahma AF, Boland JP, Witsberger T (1991) Diagnostic and therapeutic strategies of white clot syndrome. Am J Surg 162: 175
2. Amiral J, Bridey F, Dreyfus M, Vissoc AM, et al(1992) Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 68: 95
3. Amiral J, Peynaud-Debayle E, Wolf M, Bridey F, Vissac AM, Meyer D (1996) Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfracionated or low-molecular-weight heparin. Am J Hematol 52: 90
4. Astor RH (1995) Heparin-induced thrombocytopenia and thrombosis. N Engl J Med 332: 1374
5. Chong BH, Pitney WR, Castaldi PA (1982) Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis and platelet aggregation. Lancet 329: 1246
6. Chong BH, Burgess J, Ismail F (1993) The clinical usefulness of the platelet aggregation test for diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 69: 344
7. Chong BH, Pilgrim RL, Cooley MA, Chesterman CN (1993) Increased expression of platelet IgG Fc receptors in immune heparin-induced thrombocytopenia. Blood 81: 988
8. Eichler P, Greinacher A (1996) Antihirudin antibodies by recombinant hirudin in the treatment of patients with heparin-induced thrombocytopenia (HIT). Ann Hematol: 72 (abstract)
9. Ernest D, Fisher MM (1991) Heparin-induced thrombocytopenia complicated by bilateral adrenal haemorrhage. Intensive Care Med 17: 238
10. Greinacher A, Michels I, Mueller-Eckhardt C (1992) Heparin-associated thrombocytopenia: the antibody is not heparin-specific. Thromb Haemost 67: 545
11. Greinacher A, Michels I, Liebenhoff U, Preseck P, Mueller-Eckhardt C (1993) Heparin-associated thrombocytopenia: immune complexes are attached to the platelet membrane by the negative charge of highly sulphated oligosaccharides. Br J Haematol 84: 711
12. Greinacher A, Amiral J, Dummel V, Vissac A, Kiefel V, Mueller-Eckhardt C (1994) Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme linked immunosorbent assay. Transfusion 34: 381
13. Greinacher A, Pötzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C (1994) Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF-4-heparin-complex as the major antigen. Thromb Haemost 71: 247
14. Greinacher A (1995) Antigen generation in heparin-associated thrombocytopenia: the non-immunologic type and the immunologic type are closely linked in their pathogenesis. Semin Thromb Hemost 21: 106
15. Greinacher A (1996) Heparin-induzierte Thrombocytopenie. Internist 37: 1172
16. Hach-Wunderle V, Kainer K, Krug B, Müller-Berghaus G, Pötzsch B (1994) Heparin-associated thrombosis despite normal platelet counts. Lancet I "Monotype Sorts": 469
17. Horrellou MH, Conard J, Lecrubier C (1984) Persistent heparin-induced thrombocytopenia despite therapy with low molecular weight heparin. Thromb Haemost 51: 134
18. Kapsch D, Silver D (1981) Heparin-induced thrombocytopenia with thrombosis and hemorrhage. Arch Surg 116: 1423
19. King DJ, Kelton JG (1984) Heparin-associated thrombocytopenia. Ann Intern Med 100: 535
20. Laubenthal FCA, Sabin GV (1998) Heparin-induzierte Thrombocytopenie - Pathophysiologie, Klinik, Therapie, Prophylaxe. Intensivmed 35: 307
21. Lewis BE, Wallenga JM, Wallis DE (1997) Anticoagulation with novastan (argatroban) in patients with heparin-induced thrombocytopenia and .thrombosis syndrome. Semin Thromb Hemost 23: 197
22. Makhoul RG, Greenberg CS, McCann RL (1986) Heparin-associated thrombocytopenia and thrombosis: a serious clinical problem and potential solution. J Vasc Surg 4: 522
23. Markwardt F (1991) Hirudin. Semin Thromb Hemost 17: 7
24. Matsuo T, Kario K, Chikahira Y (1992) Treatment of heparin-induced thrombocytopenia by use of argatroban, a synthetic thrombin inhibitor. Br J Haematol 82: 627
25. Prull A, Nechwatal R, Mäurer W (1990) Fulminante venöse und arterielle Thrombosen unter Heparintherapie. Dtsch Med Wochenschr 115: 456
26. Reuter HD (1987) Niedermolekulares Heparin in der Therapie der heparininduzierten Thrombocytopenie. Med Klin 82: 115
27. Sheridan D, Carter C, Kelton JG (1986) A diagnostic test for heparin-induced thrombocytopenia. Blood 67: 27
28. Slocum MM, Adams JG Jr, Teel R (1996) Use of enoxaparin in patients with heparin-induced thrombocytopenia syndrome. J Vasc Surg 23: 839
29. Vun CM, Evans S, Chong BH (1996) Cross-reactivity study of low molecular weight heparins and heparinoid in heparin-induced thrombocytopenia. Thromb Res 81: 525
30. Warkentin TE, Kelton JG (1991) Heparin-induced thrombocytopenia. In: Coller BS (ed) Progress in Hemostasis and thrombosis, vol. 10. Saunders, Philadelphia, p 1
31. Warkentin TE, Kelton JG (1994) Interaction of heparin with platelets, including heparin-induced thrombocytopenia. In: Bounameaux H (ed) Low-molecular-weight heparins in prophylaxis and therapy of thromboembolic diseases. Dekker, New York, p 75
32. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG (1995) Heparin-induced thrombocytopenia in patients treated with low-molecular-weight-heparin or unfractionated heparin. N Engl J Med 332: 1330
33. Warkentin TE (1996) Heparin-induced skin lesions. Br J Haematol 92: 494
34. Warkentin TE (1996) Heparin-induced thrombocytopenia: IgG-mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia. Transfus Med Rev 10: 249
35. Warkentin TE, Kelton JG (1996) A 14-year study of heparin-induced thrombocytopenia. Am J Med 101: 502
36. Warkentin TE (1997) Heparin-induced thrombocytopenia: pathogenesis, frequency, avoidance and management. Drug Saf 5: 325
37. Warkentin TE, Elavathil LJ, Hayward CP, Johnston MA, Russett JI, Kelton JG (1997) The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med 127: 804
38. Warkentin TE, Chong BH, Greinacher A (1998) Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 79: 1
39. Weisman RE, Tobin RW (1958) Arterial embolism occuring during systemic heparin therapy. Arch Surg 76: 219